MiMedx Group Inc (NAS:MDXG)

$ 8.8 -0.11 (-1.23%) Market Cap: 1.29 Bil Enterprise Value: 1.24 Bil PE Ratio: 14.31 PB Ratio: 7.15 GF Score: 74/100

Q3 2024 MiMedx Group Inc Earnings Call Transcript
Oct 30, 2024

$5.69 (-2.07%)

Earnings
Q2 2024 MiMedx Group Inc Earnings Call Transcript
Jul 31, 2024

$7.45 (-1.84%)

Earnings
Q1 2024 MiMedx Group Inc Earnings Call Transcript
Apr 30, 2024

$6.16 (-1.60%)

Earnings
Q4 2023 MiMedx Group Inc Earnings Call Transcript
Feb 28, 2024

$8.2 (-2.38%)

Earnings
Q3 2023 MiMedx Group Inc Earnings Call Transcript
Oct 30, 2023

$6.32 (+2.76%)

Earnings
Q2 2023 MiMedx Group Inc Earnings Call Transcript
Aug 01, 2023

$7.93 (-1.73%)

Earnings
MiMedx Group Inc Investor Call Transcript
Jun 20, 2023
Q1 2023 MiMedx Group Inc Earnings Call Transcript
May 02, 2023

$3.81 (-1.04%)

Earnings
Q4 2022 MiMedx Group Inc Earnings Call Transcript
Feb 28, 2023

$4.81 (+1.91%)

Earnings
Q3 2022 MiMedx Group Inc Earnings Call Transcript
Nov 02, 2022

$2.76 (-8.61%)

Earnings
Q2 2022 MiMedx Group Inc Earnings Call Transcript
Aug 03, 2022

$3.69 (+7.27%)

Earnings
MiMedx Group Inc at H C Wainwright Global Investment Conference (Virtual) Transcript
May 24, 2022
MiMedx Group Inc at Bank of America Healthcare Conference Transcript
May 10, 2022
Q1 2022 MiMedx Group Inc Earnings Call Transcript
May 04, 2022

$4.39 (+7.33%)

Earnings
Q4 2021 MiMedx Group Inc Earnings Call Transcript
Feb 28, 2022

$5.05 (+2.02%)

Earnings
MiMedx Group Inc at JPMorgan Healthcare Conference Transcript
Jan 12, 2022
MiMedx Group Inc To Host Virtual Investor Day Transcript
Dec 07, 2021
MiMedx Group Inc at Credit Suisse Healthcare Conference (Virtual) Transcript
Nov 09, 2021
Q3 2021 MiMedx Group Inc Earnings Call Transcript
Nov 03, 2021

$8.09 (+15.08%)

Earnings
MiMedx Group Inc at H C Wainwright Global Investment Conference (Virtual) Transcript
Sep 13, 2021
Q2 2021 MiMedx Group Inc Earnings Call Transcript
Aug 04, 2021

$11.89 (-5.26%)

Earnings
MiMedx Group Inc at Raymond James Human Health Innovation Conference (Virtual) Transcript
Jun 23, 2021
MiMedx Group Inc at Bank of America Global Research Healthcare Conference (Virtual) Transcript
May 13, 2021
Q1 2021 MiMedx Group Inc Earnings Call Transcript
Apr 29, 2021

$10.18 (-4.95%)

Earnings
Q4 2020 MiMedx Group Inc Earnings Call Transcript
Mar 09, 2021

$8.96 (-9.73%)

Earnings
MiMedx Group Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 13, 2021
MiMedx Group Inc Annual Shareholders Meeting Transcript
Nov 20, 2020
Q3 2020 MiMedx Group Inc Earnings Call Transcript
Nov 05, 2020

$6.78 (-6.22%)

Earnings

Q2 2022 MiMedx Group Inc Earnings Call Transcript

Aug 03, 2022 / 12:30PM GMT

Release Date Price: $3.69 (+7.27%)

Transcript 8-K10-Q

Operator

Greetings, and welcome to the MiMedx Group Second Quarter 2022 Operational and Financial Results Conference Call. (Operator Instructions) As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Mr. Jack Howarth, Senior Vice President Investor Relations from MiMedx Group. Thank you. You may begin.

John J. Howarth

MiMedx Group, Inc. - SVP of IR

Thank you, Operator. And good morning, everyone. Welcome to the MiMedx Second Quarter 2022 Operating and Financial Results Conference Call. With me on today's call, our Chief Executive Officer, Tim Wright; Chief Financial Officer, Pete Carlson; President Wound Care and Surgical, Dr. Rohit Kashyap; and President, Regenerative Medicine and Biologics Innovation, Dr. Robert Stein. Tim and Pete will provide a summary of our operating highlights and financial results for the quarter. And at the conclusion of their remarks, Tim, Pete and doctors Kashyap and Stein will be available for your questions.

Before we begin, I would like to remind you that our comments today

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.